$LCTX 3 SEC Filings

Filed On	Filing
16 Nov 2022	Form 3: Howe Jill Ann, Chief Financial Officer No securities owned
08 Jul 2022	Form 3: Hernandez Alexandra, Sr Director Finance/Controller
02 Sep 2021	Form 3: Samuel George A. Iii, General Counsel/Secretary No securities owned
01 Jul 2021	Form 3: Cook Kevin Leon, Chief Financial Officer No securities owned
06 May 2021	Form 3: Jayasuriya Anula, Director No securities owned
22 Apr 2021	Form 3: Amin Dipti, Director No securities owned
22 Jan 2021	Form 3: Hernandez Alexandra, Sr Director Finance/Controller
22 May 2019	Form 3: Leavitt Chase C., General Counsel/Secretary No securities owned
29 Mar 2019	Form 3: Hogge Gary S., SVP,Clinical & Medical Affairs Holds 28,445 shares of Common Shares, no par value
21 Mar 2019	Form 3: Wirth Edward, Chief Medical Officer No securities owned
14 Mar 2019	Form 3: Bailey Don M, Director Holds 62,647 shares of Common Shares, no par value
09 Jan 2019	Form 3: Roberts Brandi, CFO & SVP, Finance No securities owned
19 Sep 2018	Form 3: Culley Brian M, Director No securities owned
27 Apr 2018	Form 3: Redmond Cavan M., Director
15 Feb 2017	Form 3: Patton Stephana Eilene, General Counsel
16 Nov 2016	Form 3: Knight James A., Sr VP, Head of Corporate Dev Holds 17,036 shares of Common Shares, no par value
31 Dec 2015	Form 3: Biotime Inc, 10% owner · Insight Molecular Diagnostics Inc Holds 14,674,244 shares of Common Stock, no par value
27 Nov 2015	Form 3: Skibsted Russell, Chief Financial Officer
06 Jan 2015	Form 3: Mohanty Aditya P., Chief Operating Officer
16 Dec 2014	Form 3: Russell Angus C., Director Holds 17,500 shares of Common Shares, no par value

Comments